The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases.
Ming-Cheng ChangChun-Tang ChenPing-Fang ChiangYing Cheng ChiangPublished in: Pharmaceuticals (Basel, Switzerland) (2024)
Chitinase-3-like protein-1 ( CHI3L1 ), also known as YKL40, is a glycoprotein that belongs to the chitinase protein family. It is involved in various biological functions, including cell proliferation and tissue remodeling, with inflammatory and immunomodulatory capabilities. Several studies have shown that CHI3L1 (YKL40) is upregulated in various diseases, such as cancer, asthma, and inflammatory bowel disease, among others. Although the expression level of CHI3L1 (YKL40) is associated with disease activity, severity, and prognosis, its potential as a therapeutic target is still under investigation. In this review, we summarize the biological functions, pathological roles, and potential clinical applications of specific inhibitors and targeted therapies related to CHI3L1 (YKL40).
Keyphrases
- disease activity
- papillary thyroid
- cell proliferation
- systemic lupus erythematosus
- rheumatoid arthritis
- oxidative stress
- squamous cell
- rheumatoid arthritis patients
- ankylosing spondylitis
- poor prognosis
- chronic obstructive pulmonary disease
- juvenile idiopathic arthritis
- stem cells
- lung function
- squamous cell carcinoma
- cystic fibrosis
- climate change
- drug induced
- mesenchymal stem cells
- protein protein
- air pollution
- human health
- small molecule
- smoking cessation